Morgan Stanley downgraded RXO Inc. (RXO) to Equal Weight from Overweight with a price target of $22, up from $19. The stock is up more than two-times since its November lows and is “now closer to mid-cycle fair value,” the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: